|
US3555154A
(en)
*
|
1967-08-16 |
1971-01-12 |
Armour Pharma |
Preparations containing 6 - cycloalkylguanamines and methods for treating inflammatory conditions therewith
|
|
EP0361489A3
(en)
|
1988-09-30 |
1991-06-12 |
Chugai Seiyaku Kabushiki Kaisha |
Novel 3,4-diaminoquinoline and pyridine compounds
|
|
MXPA02003436A
(es)
|
1999-10-07 |
2002-08-20 |
Amgen Inc |
Inhibidores de triazina cinasa.
|
|
TWI259081B
(en)
*
|
2001-10-26 |
2006-08-01 |
Sugen Inc |
Treatment of acute myeloid leukemia with indolinone compounds
|
|
US7467603B2
(en)
|
2004-05-24 |
2008-12-23 |
Equusys, Incorporated |
Animal instrumentation
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
CA2648804C
(en)
|
2006-04-07 |
2014-05-27 |
Methylgene Inc. |
Benzamide derivatives as inhibitors of histone deacetylase
|
|
EP2066645A2
(en)
|
2006-09-12 |
2009-06-10 |
UCB Pharma S.A. |
2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
|
|
WO2008122378A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Ucb Pharma, S.A. |
Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
|
|
JO3240B1
(ar)
|
2007-10-17 |
2018-03-08 |
Janssen Pharmaceutica Nv |
c-fms مثبطات كيناز
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
CN102625799A
(zh)
|
2009-06-25 |
2012-08-01 |
安姆根有限公司 |
杂环化合物及其用途
|
|
WO2011078143A1
(ja)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
ピリミジン誘導体およびそれらを含有する医薬組成物
|
|
EP2588471A1
(en)
|
2010-06-30 |
2013-05-08 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of pi3k activity
|
|
WO2012117048A1
(en)
|
2011-03-02 |
2012-09-07 |
Lead Discovery Center Gmbh |
Pharmaceutically active disubstituted triazine derivatives
|
|
HRP20171554T1
(hr)
|
2011-09-12 |
2017-11-17 |
Merck Patent Gmbh |
Novi imidazol amini kao modulatori aktivnosti kinaze
|
|
ES2646759T3
(es)
|
2011-09-12 |
2017-12-15 |
Merck Patent Gmbh |
Derivados de aminopirimidina para uso como moduladores de la actividad de la quinasa
|
|
MX342326B
(es)
|
2011-09-27 |
2016-09-26 |
Novartis Ag |
3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante.
|
|
SMT201800334T1
(it)
|
2012-01-06 |
2018-09-13 |
Agios Pharmaceuticals Inc |
Composti terapeuticamente attivi e loro metodi di utilizzo
|
|
JP6479667B2
(ja)
*
|
2012-10-24 |
2019-03-06 |
ビーエーエスエフ ソシエタス・ヨーロピアBasf Se |
除草性アジン
|
|
CN103044469A
(zh)
|
2012-11-30 |
2013-04-17 |
大连联化化学有限公司 |
一种制备环戊烯/环己烯-1-硼酸频哪醇酯的方法
|
|
US9862692B2
(en)
|
2013-01-23 |
2018-01-09 |
The University Of Toledo |
Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancer
|
|
CN105593215B
(zh)
|
2013-07-11 |
2019-01-15 |
安吉奥斯医药品有限公司 |
用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
|
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
WO2015003355A2
(en)
*
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
MX375030B
(es)
*
|
2013-07-11 |
2025-03-06 |
Agios Pharmaceuticals Inc |
Compuestos de n,6-bis(aril o heteroaril)-1,3,5-triazin-2,4-diamina como inhibidores de idh2 mutantes para el tratamiento de cancer.
|
|
CN105916507A
(zh)
|
2013-08-02 |
2016-08-31 |
安吉奥斯医药品有限公司 |
治疗活性化合物及其使用方法
|
|
DK3063143T3
(en)
|
2013-11-01 |
2018-08-20 |
Novartis Ag |
Amino heteroaryl benzamides as kinase inhibitors
|
|
WO2015187088A1
(en)
|
2014-06-04 |
2015-12-10 |
Thomas Helledays Stiftelse För Medicinsk Forskning |
Mth1 inhibitors for treatment of cancer
|
|
CN106794181A
(zh)
|
2014-06-04 |
2017-05-31 |
托马斯·黑勒戴药物研究基金会 |
用于治疗炎性和自身免疫性病况的mth1抑制剂
|
|
KR102526632B1
(ko)
*
|
2014-11-19 |
2023-04-27 |
엔제트피 유케이 리미티드 |
스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드
|
|
WO2016119707A1
(en)
*
|
2015-01-29 |
2016-08-04 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
|
AU2016299092B2
(en)
|
2015-07-30 |
2020-08-20 |
Centaurus Biopharma Co., Ltd. |
1, 3, 5-triazine derivative and method of using same
|
|
WO2017059280A1
(en)
|
2015-10-02 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Novel pan-tam inhibitors and mer/axl dual inhibitors
|
|
MA43374A
(fr)
|
2015-12-04 |
2018-10-10 |
Agios Pharmaceuticals Inc |
Méthodes de traitement de tumeurs malignes
|
|
WO2017096945A1
(zh)
|
2015-12-07 |
2017-06-15 |
北京康美特科技股份有限公司 |
含硼有机硅化合物、太阳能电池组件用密封剂以及太阳能电池组件
|
|
IL307931A
(en)
|
2016-04-15 |
2023-12-01 |
Epizyme Inc |
Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors
|
|
CN107382840B
(zh)
|
2016-05-16 |
2020-09-01 |
四川大学 |
吡啶类化合物及其作为idh功能变异突变体抑制剂类药物的用途
|
|
CR20200124A
(es)
|
2017-08-15 |
2020-09-28 |
Abbvie Inc |
Inhibidores macrocíclicos de mcl-1 y métodos de uso
|
|
CN109467538A
(zh)
*
|
2017-09-07 |
2019-03-15 |
和记黄埔医药(上海)有限公司 |
环烯烃取代的杂芳环类化合物及其用途
|
|
TWI707859B
(zh)
|
2017-09-07 |
2020-10-21 |
日商衛材R&D企管股份有限公司 |
五環化合物
|